SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-060449
Filing Date
2024-05-15
Accepted
2024-05-15 16:09:51
Documents
12
Period of Report
2024-05-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K engn-20240515.htm   iXBRL 8-K 72731
2 EX-10.1 engn-ex10_1.htm EX-10.1 197168
  Complete submission text file 0000950170-24-060449.txt   454346

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT engn-20240515.xsd EX-101.SCH 47328
15 EXTRACTED XBRL INSTANCE DOCUMENT engn-20240515_htm.xml XML 6764
Mailing Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1
Business Address 4868 RUE LEVY, SUITE 220 SAINT-LAURENT A8 H4R 2P1 (514) 332-4888
enGene Holdings Inc. (Filer) CIK: 0001980845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-41854 | Film No.: 24950640
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)